Tag
An experimental mRNA-based cancer vaccine has successfully prevented melanoma from returning in a late-stage study, marking the first validation of decades of custom-treatment research.
404 Media investigation reveals that Research Gold, a service advertising '100% human-written' medical peer reviews, is entirely AI-operated with fabricated staff credentials and AI-generated responses.
Scientists have developed an AI platform called CenSegNet to analyze centrosomes in breast cancer tumours, uncovering new patterns that can predict cancer progression and lead to personalized treatments.
Tadalafil, known as Cialis for erectile dysfunction, is being repurposed for longevity benefits, with observational studies showing associations with reduced cardiovascular disease and dementia, though causality is not yet established.
Research explores applying photosynthetic processes to develop new treatments for dry eye disease.
The National Institutes of Health (NIH) is ending a key grant program that supports early-career clinical researchers, potentially impacting their career development and research funding.
The article points out the misuse of the term 'kidney disappointment' instead of 'kidney failure' in several research papers, as identified through Google Scholar searches.
A study published in JACC shows that waist circumference and waist-to-hip ratio are better predictors of heart disease risk than BMI alone, indicating that relying solely on BMI may misclassify cardiovascular risk.
A controversial Alzheimer's surgery is claimed to reverse symptoms, indicating a potential breakthrough in medical treatment for the disease.
A study in JAMA Surgery reports that wait times for cancer surgery in the US have increased across six cancer types between 2012 and 2023, with longer delays associated with poorer outcomes.
Virologist Beata Halassy self-treated her recurrent breast cancer with lab-prepared viruses, achieving remission and redirecting her research to oncolytic virotherapy.
A doctor refutes claims of covered-up vaccine miscarriage data by noting it was published publicly in NEJM, showing no increased risk, and explains the 82% figure results from a denominator error.
A medical study examining how midlife vascular risk burden affects dementia-free survival years, providing insights into preventative health measures.
Eric Topol highlights a BMJ study showing tirzepatide (Zepbound) reduces cardiovascular events, infections by 36%, and all-cause mortality by 45% compared to sitagliptin in diabetic patients with prior atherosclerotic cardiovascular disease.
Early clinical trial results suggest psilocybin, the active ingredient in magic mushrooms, could kick-start recovery in anorexia patients, offering a potential new treatment for a disorder with high mortality and limited effective therapies.
AIPOCH has released a curated library of over 550 medical research agent skills supporting evidence insights, protocol design, data analysis, and academic writing, compatible with multiple AI agent platforms like Claude Code and Codex.
This paper presents an evidence-grounded AI framework for diagnosing and treating musculoskeletal conditions, leveraging clinical data and orthopedic knowledge.
A CDC study published in Morbidity and Mortality Weekly Report found that in some parts of the US, up to 30% of people carry antibodies for alpha-gal syndrome, a red meat allergy triggered by tick bites, far exceeding the previously estimated 0.14% prevalence.
This exploratory study evaluates whether augmenting AI agents with a medical research skill package improves the quality of transcriptomic research analysis outputs compared to native AI, using a multi-model human evaluation in an NSCLC biomarker task. Results show a directional but statistically non-significant improvement, highlighting the need for larger, more robust evaluations.
Pioneering Australian melanoma doctor Richard Scolyer has died at 59 after undergoing a world-first experimental immunotherapy treatment for glioblastoma. His work with Georgina Long dramatically improved survival rates for advanced melanoma patients.